NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.88
+0.0171 (+1.98%)
At Close: May 09, 2024
ABMC Reports Fourth Quarter and Year End 2019 Results | | IT Business Net
09:11pm, Friday, 26'th Jun 2020
KINDERHOOK, NY / ACCESSWIRE / June 26, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2019. Chief Executive
Amarin (AMRN) Gains But Lags Market: What You Should Know
09:50pm, Thursday, 25'th Jun 2020
In the latest trading session, Amarin (AMRN) closed at $6.92, marking a +0.58% move from the previous day.
Maharashtra and Delhi among States to Get First Set of Covid-19 Drug Covifor from Hetero
01:06pm, Thursday, 25'th Jun 2020
The company said it has fixed a maximum retail price of Rs 5,400 per vial for the drug.
Maharashtra, Delhi among 5 states to receive first batch of COVID-19 drug
10:42am, Thursday, 25'th Jun 2020
Hetero Healthcare is set to deliver the first batch of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, and Maharashtr
Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India
04:55pm, Wednesday, 24'th Jun 2020
The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts
Explained: The various drugs being used for treating Covid-19 symptoms in India now
03:39pm, Wednesday, 24'th Jun 2020
Coronavirus (Covid-19) Medicine Latest Update: Companies have launched generic versions of Remdesivir and Favipiravir to aid in the treatment of Covid-19, in specific cases, while UK has authorised th
Hetero Set to Supply 20,00 Vials of Covifor at Rs 5,400 Each for Covid-19 Treatment
11:00am, Wednesday, 24'th Jun 2020
One set would be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, a press release from the city-based drug-maker said.
Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India
10:47am, Wednesday, 24'th Jun 2020Cipremi: Cipla to price remdesivir version for COVID-19 drug under Rs 5,000
08:24am, Wednesday, 24'th Jun 2020
Mumbai-based drugmaker Cipla on Tuesday announced that it will price 'Cipremi', its generic version of Gilead Sciences Inc's antiviral drug remdesivir for use in Covid-19 patients, at less than ₹5,0
Zydus Cadila gets USFDA nod to market generic antihistamine tablets
08:22am, Wednesday, 24'th Jun 2020
The drug will be manufactured at the group's manufacturing facility in Ahmedabad
COVID-19 drug: Cipla to price generic version of remdesivir below Rs 5,000 per vial, to be available in 8-10 days
09:02pm, Tuesday, 23'rd Jun 2020
Hyderabad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose.
Concerns vapers will take up smoking if proposal to ban liquid nicotine goes ahead
08:19pm, Tuesday, 23'rd Jun 2020
Around 2,000 small businesses are at risk and 300,000 vapers could potentially return to cigarette smoking, advocates say, if the Health Minister's proposal to ban liquid nicotine imports is approved.
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
03:33pm, Tuesday, 23'rd Jun 2020
Pharma major Cipla will price its generic version of antiviral drug remdesivir at less than Rs 5,000 per vial in keeping with its conviction of providing access to the medicines at affordable cost, th
Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial
03:32pm, Tuesday, 23'rd Jun 2020
Hyderbad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose
